医疗保健 · Healthcare
打开互动页面（K 线、成交价图）Open interactive page →
IRD · Opus Genetics, Inc.
内部人交易（Form 4）· Insider trading · 2026-07-01 – 2026-10-22
Opus Genetics, Inc.（IRD）内部人交易：2026-07-01 至 2026-10-22，内部人公开市场买入 —、卖出 $3.0M；高管董事有效买入 —、有效卖出 $2.8M。最近申报 2026-10-02。
买入 Bought—
卖出 Sold$3.0M
有效买入 Effective bought—
有效卖出 Effective sold$2.8M
最近申报 Recent filings
| 交易日 | 内部人 | 类型 | 股数 | 价格 | 金额 | |
|---|---|---|---|---|---|---|
| 2026-09-30 | Foundation Fighting Blindness Retinal Degeneration Fund Director, Other | 卖出 Sell · 有效 | 556,000 | $4.96 | $2.8M | SEC |
| 2026-09-03 | Gagnon Robert E. Chief Financial Officer | 卖出 Sell | 28,000 | $4.54 | $127K | SEC |
| 2026-07-23 | Gagnon Robert E. Chief Financial Officer | 卖出 Sell | 7,783 | $2.95 | $23K | SEC |
| 2026-07-23 | Magrath George Chief Executive Officer, Director | 卖出 Sell | 9,475 | $2.95 | $28K | SEC |
| 2026-07-23 | SCHACHLE JOSEPH K Chief Operating Officer | 卖出 Sell | 4,644 | $2.94 | $14K | SEC |
| 2026-07-23 | YERXA BENJAMIN R Director, President | 卖出 Sell | 7,429 | $2.97 | $22K | SEC |
「有效」= 高管或董事的公开市场主动买卖，排除 10b5-1 计划、行权卖出、缴税卖出、IPO/认购等。
拟出售 Form 144
| 预计出售日 | 申报人 | 股数 | 约金额 | |
|---|---|---|---|---|
| 2026-09-03 | Gagnon Robert E. Officer | 28,000 | $125K | 10b5-1 |
| 2026-07-23 | Magrath George Officer | 9,475 | $29K | |
| 2026-07-23 | Gagnon Robert E. Officer | 7,783 | $24K | |
| 2026-07-23 | YERXA BENJAMIN R Officer | 7,429 | $22K | |
| 2026-07-23 | SCHACHLE JOSEPH K Officer | 4,644 | $14K |
内部人 Insiders
Foundation Fighting Blindness Retinal Degeneration Fund、Gagnon Robert E.、Magrath George、SCHACHLE JOSEPH K、YERXA BENJAMIN R